Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru

Authors

  • Jorge Alberto Gomez GSK Vaccines Latin America, Victoria, Buenos Aires, Argentina
  • Maria Mercedes Castrejon GSK Vaccines Latin America, Panamá, Panamá
  • Nicolas Van de Velde GSK Vaccines, Wavre, Belgium

DOI:

https://doi.org/10.3855/jidc.6827

Keywords:

Cost effectiveness, pneumococcal vaccines, Peru

Abstract

This item has no abstract. Follow the links below to access the full text.
👁 Abstract Views: 944📥 PDF Downloads: 755

Author Biography

Jorge Alberto Gomez, GSK Vaccines Latin America, Victoria, Buenos Aires, Argentina

Senior Healrh Economic ManagerGSK Vaccines, Latin America

Downloads

Published

2015-07-30

How to Cite

1.
Gomez JA, Castrejon MM, Van de Velde N (2015) Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru. J Infect Dev Ctries 9:796–798. doi: 10.3855/jidc.6827

Issue

Section

Letters to the Editor